Summary
Latest filing:
Rebecca Byam is Chief Financial Officer of HCW Biologics Inc. (HCWB). 1 SEC Form 4 filing on record, dated 27 May 2026. Most recent open-market trade: bought $20K of HCWB on 27 May 2026. Lifetime open-market purchases: $20K.
Recent Transactions
1Every recent SEC Form 4 transaction Rebecca Byam has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Rebecca Byam files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Scott T. Garrett - $270K of HCWB open-market activity in the last 12 months
- Hing C. Wong - $220K of HCWB open-market activity in the last 12 months
- Lee Flowers - $20K of HCWB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rebecca Byam?
Rebecca Byam is a corporate insider, tracked as Chief Financial Officer of HCW Biologics Inc. (HCWB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Rebecca Byam last file a Form 4?
The only primary Form 4 on record is dated 27 May 2026.
Has Rebecca Byam been buying or selling stock?
Recorded transactions: 2 open-market purchases ($20K) and 0 open-market sales across all tracked filings.
Where can I see all of Rebecca Byam's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rebecca Byam and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
